The report forecasts the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of 8.36% during the period 2016-2020.
Commenting on the report, an analyst from the research team said: One trend that will boost the market is the growing popularity of robotic-assistance surgery. Robotic surgery is rapidly evolving and also successfully investigated for the implantation of CRT-D in patients. In few instances, the manual implantation of CRT-D may not be possible due to anatomic limitations. The introduction of robotic systems is one of the noteworthy advancements in minimally invasive cardiac surgeries. Robotic technology provides physicians with an excellent view of the operative field and the ability to manoeuvre instruments within close-fitting spaces with precision and control. Robotic surgical procedures help to reduce patients' hospital stays and facilitate better cost management.
According to the report, a key growth driver is clinical considerations to make a switch to CRT-D technology. The switching from CRT-P to CRT-D, owing to clinical considerations, will propel the market growth. Clinical research studies show that CRT-D devices can reduce re-admissions to hospital for individuals with heart failure. In people with ischaemic cardiomyopathy or ischemic etiology, CRT-D implantation has showed better survival rate than CRT-P devices. There are incremental benefits in CRT-D devices compared to CRT-P devices, as it reduces the risk of sudden cardiac death (SCD) and improves the left ventricular function.
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
St. Jude Medical
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Cost analysis of CRT-D device implantation